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What you need to know:

**Background and Context:** Gene expression patterns of CD8^+^ T cells was reported to correlate with outcomes of adults with inflammatory bowel diseases (IBD). T-cell exhaustion has been associated with IBD progression.

**New Findings**: Transcription and DNA methylation patterns of CD8^+^ T cells vary with patient age, sex, and IBD vs no IBD but do not correlate with outcome.

**Limitations**: This was a study of 112 pediatric IBD patients and 19 controls; larger studies are needed.

**Impact**: The findings reveal the challenges of developing tests that determine prognoses of patients with IBD. All proposed prognostic markers must be validated in large, independent cohorts before they can be used in the clinic.

**Lay Summary**: The authors found that gene expression and DNA methylation patterns in immune cells do not correlate with outcomes of children and adults with IBD, and therefore do not currently support their use to determine prognosis.
